Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali Ikhsanul Qauli

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Frontiers in Physiology|September 13, 2021
Sensitivity Analysis of Ion Channel Conductance on Myocardial Electromechanical Delay: Computational StudyAli Ikhsanul Qauli, Aroli Marcellinus, Ki Moo Lim
Bioengineering (Basel, Switzerland)|October 27, 2022
Verification of the Efficacy of Mexiletine Treatment for the A1656D Mutation on Downgrading Reentrant Tachycardia Using a 3D Cardiac Electrophysiological ModelAli Ikhsanul Qauli, Yedam Yoo, Aroli Marcellinus, et al.
Toxicology and Applied Pharmacology|June 23, 2026
Improving biomarker robustness for in silico cardiac safety assessment through an excitation-contraction coupling modelUlfa Latifa Hanum, Ali Ikhsanul Qauli, Ariyadi, et al.
Translational and Clinical Pharmacology|July 8, 2024
Development of <i>in-silico</i> drug cardiac toxicity evaluation system with consideration of inter-individual variabilityAli Ikhsanul Qauli, Rakha Zharfarizqi Danadibrata, Aroli Marcellinus, et al.
Biomedical Engineering Letters|January 26, 2026
A multiscale computational model of cardiac electrophysiology for drug-induced pro-arrhythmic risk stratificationAna Rahma Yuniarti, Aroli Marcellinus, Ali Ikhsanul Qauli, et al.
Translational and Clinical Pharmacology|January 13, 2025
Cardiotoxicity evaluation of two-drug fixed-dose combination therapy under CiPA: a computational studyAli Ikhsanul Qauli, Aroli Marcellinus, Frederique Jos Vanheusden, et al.
Toxicological Research|July 6, 2026
<i>In silico</i> cardiac safety assessment using a multi-biomarker approach based on an electrophysiological model of hiPSC-derived cardiomyocytesAri Kurniawan Saputra, Ali Ikhsanul Qauli, Aroli Marcellinus, et al.
Frontiers in Physiology|April 19, 2024
Evaluation of cardiac pro-arrhythmic risks using the artificial neural network with ToR-ORd <i>in silico</i> model outputNurul Qashri Mahardika T, Ali Ikhsanul Qauli, Aroli Marcellinus, et al.
Scientific Reports|October 14, 2024
Explainable artificial intelligence (XAI) to find optimal in-silico biomarkers for cardiac drug toxicity evaluationMuhammad Adnan Pramudito, Yunendah Nur Fuadah, Ali Ikhsanul Qauli, et al.
Frontiers in Physiology|October 20, 2023
Machine learning approach to evaluate TdP risk of drugs using cardiac electrophysiological model including inter-individual variabilityYunendah Nur Fuadah, Ali Ikhsanul Qauli, Aroli Marcellinus, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Frontiers in Physiology|September 13, 2021
Sensitivity Analysis of Ion Channel Conductance on Myocardial Electromechanical Delay: Computational StudyAli Ikhsanul Qauli, Aroli Marcellinus, Ki Moo Lim
Bioengineering (Basel, Switzerland)|October 27, 2022
Verification of the Efficacy of Mexiletine Treatment for the A1656D Mutation on Downgrading Reentrant Tachycardia Using a 3D Cardiac Electrophysiological ModelAli Ikhsanul Qauli, Yedam Yoo, Aroli Marcellinus, et al.
Toxicology and Applied Pharmacology|June 23, 2026
Improving biomarker robustness for in silico cardiac safety assessment through an excitation-contraction coupling modelUlfa Latifa Hanum, Ali Ikhsanul Qauli, Ariyadi, et al.
Translational and Clinical Pharmacology|July 8, 2024
Development of <i>in-silico</i> drug cardiac toxicity evaluation system with consideration of inter-individual variabilityAli Ikhsanul Qauli, Rakha Zharfarizqi Danadibrata, Aroli Marcellinus, et al.
Biomedical Engineering Letters|January 26, 2026
A multiscale computational model of cardiac electrophysiology for drug-induced pro-arrhythmic risk stratificationAna Rahma Yuniarti, Aroli Marcellinus, Ali Ikhsanul Qauli, et al.
Translational and Clinical Pharmacology|January 13, 2025
Cardiotoxicity evaluation of two-drug fixed-dose combination therapy under CiPA: a computational studyAli Ikhsanul Qauli, Aroli Marcellinus, Frederique Jos Vanheusden, et al.
Toxicological Research|July 6, 2026
<i>In silico</i> cardiac safety assessment using a multi-biomarker approach based on an electrophysiological model of hiPSC-derived cardiomyocytesAri Kurniawan Saputra, Ali Ikhsanul Qauli, Aroli Marcellinus, et al.
Frontiers in Physiology|April 19, 2024
Evaluation of cardiac pro-arrhythmic risks using the artificial neural network with ToR-ORd <i>in silico</i> model outputNurul Qashri Mahardika T, Ali Ikhsanul Qauli, Aroli Marcellinus, et al.
Scientific Reports|October 14, 2024
Explainable artificial intelligence (XAI) to find optimal in-silico biomarkers for cardiac drug toxicity evaluationMuhammad Adnan Pramudito, Yunendah Nur Fuadah, Ali Ikhsanul Qauli, et al.
Frontiers in Physiology|October 20, 2023
Machine learning approach to evaluate TdP risk of drugs using cardiac electrophysiological model including inter-individual variabilityYunendah Nur Fuadah, Ali Ikhsanul Qauli, Aroli Marcellinus, et al.
Pageof 2